These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 8352803)

  • 1. c-MYC repression of promoter activity through core promoter elements.
    Lucas JM; Wilkie NM; Lang JC
    Biochem Biophys Res Commun; 1993 Aug; 194(3):1446-52. PubMed ID: 8352803
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of the c-fms gene in fibroblast cells by c-Myc-MM-1-TIF1beta complex.
    Satou A; Hagio Y; Taira T; Iguchi-Ariga SM; Ariga H
    FEBS Lett; 2004 Aug; 572(1-3):211-5. PubMed ID: 15304350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autorepression of c-myc requires both initiator and E2F-binding site elements and cooperation with the p107 gene product.
    Luo Q; Li J; Cenkci B; Kretzner L
    Oncogene; 2004 Feb; 23(5):1088-97. PubMed ID: 14716294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo.
    Lavenu A; Pournin S; Babinet C; Morello D
    Oncogene; 1994 Feb; 9(2):527-36. PubMed ID: 8290263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of c-myc transcription in vitro: dependence on the guanine-rich promoter element ME1a1.
    Hall DJ
    Oncogene; 1990 Jan; 5(1):47-54. PubMed ID: 2181377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. c-Myc inhibits CD11a and CD11c leukocyte integrin promoters.
    López-Rodríguez C; Delgado MD; Puig-Kröger A; Nueda A; Muñoz E; León J; Bernabéu C; Corbi AL
    Eur J Immunol; 2000 Sep; 30(9):2465-71. PubMed ID: 11009078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug targeting of the c-MYC promoter to repress gene expression via a G-quadruplex silencer element.
    Hurley LH; Von Hoff DD; Siddiqui-Jain A; Yang D
    Semin Oncol; 2006 Aug; 33(4):498-512. PubMed ID: 16890804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo complex formation of PU.1 with HDAC1 associated with PU.1-mediated transcriptional repression.
    Kihara-Negishi F; Yamamoto H; Suzuki M; Yamada T; Sakurai T; Tamura T; Oikawa T
    Oncogene; 2001 Sep; 20(42):6039-47. PubMed ID: 11593411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of the proto-oncogene c-myc through t(8;22) translocation in Burkitt's lymphoma.
    Gerbitz A; Mautner J; Geltinger C; Hörtnagel K; Christoph B; Asenbauer H; Klobeck G; Polack A; Bornkamm GW
    Oncogene; 1999 Mar; 18(9):1745-53. PubMed ID: 10208435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The c-myc promoter: still MysterY and challenge.
    Wierstra I; Alves J
    Adv Cancer Res; 2008; 99():113-333. PubMed ID: 18037408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
    Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
    Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. pRb, Myc and p53 are critically involved in SV40 large T antigen repression of PDGF beta-receptor transcription.
    Uramoto H; Hackzell A; Wetterskog D; Ballági A; Izumi H; Funa K
    J Cell Sci; 2004 Aug; 117(Pt 17):3855-65. PubMed ID: 15265983
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human differentiation-related gene NDRG1 is a Myc downstream-regulated gene that is repressed by Myc on the core promoter region.
    Zhang J; Chen S; Zhang W; Zhang J; Liu X; Shi H; Che H; Wang W; Li F; Yao L
    Gene; 2008 Jul; 417(1-2):5-12. PubMed ID: 18455888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Repression of transcription of the p27(Kip1) cyclin-dependent kinase inhibitor gene by c-Myc.
    Yang W; Shen J; Wu M; Arsura M; FitzGerald M; Suldan Z; Kim DW; Hofmann CS; Pianetti S; Romieu-Mourez R; Freedman LP; Sonenshein GE
    Oncogene; 2001 Mar; 20(14):1688-702. PubMed ID: 11313917
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoregulation of the human N-myc oncogene is disrupted in amplified but not single-copy neuroblastoma cell lines.
    Sivak LE; Tai KF; Smith RS; Dillon PA; Brodeur GM; Carroll WL
    Oncogene; 1997 Oct; 15(16):1937-46. PubMed ID: 9365240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
    Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
    J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of the matrix metalloproteinase-9 gene in an H-ras and v-myc transformed rat embryo cell line.
    Himelstein BP; Lee EJ; Sato H; Seiki M; Muschel RJ
    Oncogene; 1997 Apr; 14(16):1995-8. PubMed ID: 9150367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
    Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
    Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.